Industries · Cell & Gene Therapy
OMICS4 runs the molecular characterization behind your cell engineering and gene therapy programs (transcriptomic profiling, vector and expression quantification, and QC), bookable in-house and through our partner network.
Platforms used in this field
Overview
OMICS4 runs the molecular work behind cell and gene therapy programmes: engineered cells profiled, vector copy number quantified, QC documented at every checkpoint. Your internal lot IDs travel with the samples from reception to report.
Platforms
Bulk and single-cell profiling of engineered cells.
Vector copy number, precisely.
Sequencing for integration work.
Documented QC at each development checkpoint.
Engineered and control cells, cell pellets, culture supernatant, vector preparations and tissue. Input and quality criteria are published per sample type, for DNA and for RNA. Every sample carries your internal lot ID from reception onward.
Your internal lot IDs travel with the samples end to end and appear on the QC report, so a result can be matched to a batch without a translation table. QC checkpoints are scheduled against your milestone calendar rather than a fixed laboratory queue.
A QC report for every sample. Sequencing files and, where the service covers it, aligned and quantified outputs. Result tables for PCR and protein work. Exports in the formats your team already imports, and turnaround published per service.
Analysis, integration, biomarker discovery and modelling are not part of a platform booking. They are run by GenXMap’s computational team. Ask for them in the quote request and both are scoped together.
Analysis at GenXMapHave a project in this space?